|
V56602
|
Y-134
|
849662-80-2 |
Y134 is a selective and orally bioactive estrogen receptor (ER) modulator (SERM) that displays potent antagonist activity against ERα and ERβ. |
|
V56699
|
YCN47284
|
181147-28-4 |
YCN47284 is an aromatic amidinohydrazone compound with antimalarial activity. |
|
V56751
|
YW2065
|
2131223-85-1 |
YW2065 has excellent anti-colorectal cancer effects both in vitro and in vivo. |
|
V56639
|
Z16078526
|
852222-94-7 |
Z16078526 induces endogenous Ucp1 expression and promotes p38 MAPK phosphorylation and lipolysis in primary mouse brown adipocytes. |
|
V56689
|
ZINC40099027
|
1211825-25-0 |
ZINC40099027, also known as ZN27, is a specific focal adhesion kinase (FAK) activator that promotes mucosal wound closure in mice after ischemic or NSAID-induced injury. |
|
V56786
|
ZM-226600
|
147695-92-9 |
ZM-226600 is a potent Kir6 (KATP) channel opener (EC50 = 0.5 μM) that lacks anti-androgenic properties. |
|
V56723
|
Zunsemetinib M-atropisomer
|
1640282-44-5 |
Zunsemetinib M-atropisomer is the inactive isomer of Zunsemetinib. |
|
V56685
|
α-Glucosidase-IN-22
|
2870693-28-8 |
α-Glucosidase-IN-22 (compound 7i) is a benzimidazole and a potent α-glucosidase inhibitor (antagonist) with IC50 of 0.64 μM. |